AI drug discovery company
Generare
Data as of .
Company facts
-
Founded
2023
-
Headquarters
France (Paris)
Latest funding round
- Round
- Series A
- Date
- Apr 2, 2026
- Amount
- EUR 20M (approx. $23.1M)
- Lead investor
- Alven and Daphni (co-leads)
Recent news
-
Series A: EUR 20M (approx. $23.1M)
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.